Related Experiment Video
Updated: Jul 19, 2026

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
Published on: October 22, 2014
Is the ankle-brachial index a useful screening test for subclinical atherosclerosis in asymptomatic, middle-aged
Rachael A Wyman1, Jon G Keevil, Kjersten L Busse
1University of Wisconsin School of Medicine and Public Health, Division of Cardiovascular Medicine, Madison, Wis, USA.
Insights
The ankle-brachial index (ABI) is not a sensitive screening tool for detecting subclinical atherosclerosis in asymptomatic middle-aged individuals, despite current recommendations for cardiovascular risk prediction.
Area of Science:
- Vascular Medicine
- Cardiovascular Risk Assessment
Background:
- Ankle-brachial index (ABI) is recommended for cardiovascular risk screening in individuals aged 50 and older.
- Limited data exists on ABI's utility in patients referred for non-invasive cardiovascular risk testing.
Purpose of the Study:
- To evaluate the ankle-brachial index (ABI) as a screening tool for subclinical atherosclerosis.
- To assess ABI's effectiveness in asymptomatic individuals referred for non-invasive cardiovascular risk assessment.
Main Methods:
- 493 asymptomatic patients without known atherosclerotic vascular disease were included.
- Patients underwent ABI measurement and carotid intima-media thickness (CIMT) ultrasound.
- ABI values were categorized as reduced (<0.9), normal (0.9-1.3), or increased (>1.3).
Main Results:
- Only 1 patient (0.2%) had a reduced ABI.
- ABI values showed a trend towards being higher with increased CIMT (P=0.051).
- No significant differences in cardiovascular risk factors or carotid plaque were found among ABI groups.
Conclusions:
- The ankle-brachial index (ABI) demonstrates low sensitivity for detecting subclinical atherosclerosis in asymptomatic middle-aged individuals.
- Current recommendations for using ABI as a screening tool may not be effective in this population.
Background:
Measurement of the ankle-brachial index (ABI) is recommended as a screening test for cardiovascular risk prediction in individuals > or = 50 years old; however, there is little data regarding the utility of the ABI as a screening test in individuals for whom physicians actually order non-invasive testing for cardiovascular risk prediction.
Methods:
This study included 493 consecutive asymptomatic patients without known atherosclerotic vascular disease who were referred by their physician for measurement of the ABI and ultrasound measurement of carotid intima-media thickness (CIMT). ABI values were classified as "reduced" (<0.9), "normal" (0.9-1.3), and "increased" (>1.3).
Results:
The mean age of the patients was 55.3 (standard deviation 7.5) years. Only 1 patient had a reduced ABI (0.2%). ABI values tended to be higher in those with increased CIMT (P=0.051); however, CIMT was not significantly different between those with normal and increased ABI values (P=0.802). There were no significant differences in the prevalence of traditional cardiovascular risk factors or carotid plaque presence among the ABI groups.
Conclusions:
Despite recommendations, the ABI is not sensitive as a screening tool for detecting subclinical atherosclerosis in asymptomatic middle-aged individuals.
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Assessment of blood pressure in brachial artery(one-step method)
Prepare for the Procedure:
Assessment of blood pressure in brachial artery(two-step method)
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Aneurysm II: Clinical Manifestations and Diagnostic Studies